Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
Asset
(881)
News
(641)
SEC filing
(370)
Event
(219)
Landing page
(64)
Person
(54)
Governance committee
(8)
Filter by content year
2024
(135)
2023
(301)
2022
(594)
2021
(446)
2020
(496)
2019
(64)
2018
(11)
2017
(4)
2016
(15)
2015
(16)
Filter by form group
Filter by category
Filter by category
Search
Event
Wolfe Healthcare Conference
Event
SVB Leerink Oncology 1x1 Day
Event
SVB Leerink Oncology 1x1 Day
News
Pfizer und BioNTech geben erfolgreiche erste Zwischenanalyse ihres COVID-19-Impfstoffkandidaten in laufender Phase-3-Studie bekannt
News
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
SEC Filings
Form 6-K
SEC Filings
Form 6-K
SEC Filings
Form F-3ASR
SEC Filings
Form 6-K
News
BioNTech veröffentlicht Ergebnisse des dritten Quartals und Informationen zur Geschäftsentwicklung
Pagination
Page 1
Next page
››